Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies

Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:08:13.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record page shows a 403 Forbidden message and a Home link instead of study details.
    Difference
    0.5%
    Check dated 2026-10-05T19:00:26.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the normal study details. As a result, users cannot view the NCT01084252 study record or related information.
    Difference
    22%
    Check dated 2026-09-21T20:48:42.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The list of recruitment sites was updated to add Tel Litwinsky, Israel and remove Qiryat Krinitzi, Israel.
    Difference
    0.0%
    Check dated 2026-09-14T18:02:37.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 was removed and Qiryat Krinitzi, Israel, 52621 was added to the study's locations. These changes modify the list of participating sites in Israel and may affect where patients can enroll.
    Difference
    0.1%
    Check dated 2026-08-31T17:50:23.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, indicating a minor update to the page or its underlying components. This reflects a version increment rather than a substantive change to content.
    Difference
    0.0%
    Check dated 2026-08-10T11:32:31.000Z thumbnail image

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.